Theyll utilize real-world electronic health records, machine learning, and other novel methods to investigate changes in obesity-related healthcare usage before and after the emergence of these medications, as well as identify predictors of GLP-1-assisted weight loss, the drugs effectiveness by subpopulation, and how these rapidly evolving therapies may influence future life expectancy based on policy changes that address the existing disparities in access and use.
My experience is personal, and while I'm thrilled with my results, professional medical advice is always paramount
However, researchers soon observed modest but consistent reductions in systolic blood pressure among treated patients
Few studies account for menopausal status, menstrual cycle phase, oral contraceptive use, or hormone replacement therapy, which could meaningfully modify response
The dual metabolic benefit, meaningful weight loss alongside glycemic control, is clinically relevant for the large subset of patients who present with both conditions
J Clin Endocrinol Metab 101(8):31553162
